Feeding mice the trans-10, cis-12 (t10c12) conjugated linoleic acid (CLA) isomer is associated with lipodystrophy, insulin resistance, hyperinsulinemia, and liver steatosis. It has been hypothesized that CLA-induced liver steatosis is the result of increased hepatic lipogenesis stimulated by high insulin levels. We studied the effects of a 12-d t10c12CLA treatment
Introduction
Conjugated linoleic acids (CLA) 3 refer to a group of dienoic derivatives of linoleic acid cis-9,cis-12 18:2(n-6). In most feeding studies, CLA are mainly represented by cis-9,trans-11 18:2(n-7), the main natural isomer produced in ruminants, and by trans-10, cis-12 18:2(n-6) (t10c12CLA), which essentially originates from vegetable oil processing. During the last decade, dietary supplementation with CLA mixtures and t10c12-isomer alone was associated with reduced fat mass in rodents (1) (2) (3) , suggesting that t10c12CLA may be useful as a weight loss agent. In humans, some studies also indicated a correlation between CLA consumption and the degree of body weight loss (4) (5) (6) (7) (8) . Even if CLA have been shown to reduce hyperglycemia in severely insulin-resistant Zucker diabetic rats and, consequently, have been considered as a potential insulin-sensitizing agent (9, 10) , there is conflicting information on CLA isomer(s) role in beneficial effects on body composition, glucose tolerance, and lipid metabolism in rodents and humans. Obviously, there is some evidence that CLA may give rise to deleterious effects on insulin sensitivity and glycemic control in animals and human studies (11) (12) (13) (14) (15) . In mice, t10c12CLA-induced alterations of lipid and carbohydrate metabolism are particularly marked and associated with severe lipodystrophy, hyperinsulinemia, and liver steatosis (12, (16) (17) (18) . Accumulating evidence indicates that an increase in lipogenesis is primarily responsible for liver triglyceride (TG) accumulation, which may be due to the conversion of glucose not metabolized by atrophied adipose tissue (19) (20) (21) . Nevertheless, we recently observed that t10c12CLA strongly increased mRNA levels of genes involved in hepatic lipid uptake, suggesting that circulating lipids could also account for TG enrichment (22) .
Our primary objective in this study was to explore the mechanisms of t10c12CLA-induced steatosis in a setting where glucose compared with plasma lipid contribution to TG formation could be distinguished. Because insulin is required in the liver for the production of fatty acids (FA) via lipogenic enzyme activity (23, 24) , we used streptozotocin (STZ)-injected mice to suppress insulin production. To our knowledge, this is the first time that the impact of t10c12CLA feeding has been studied in conditions of insulin deficiency; we therefore also determined whether t10c12CLA could influence some antidiabetic properties in STZ-injected mice. Consistent with this, we examined the effects of t10c12CLA on various metabolic variables and gene expression related to carbohydrate and lipid metabolism.
Materials and Methods
Animals and study design. Official French regulations (no. 87848) for the use and care of laboratory animals were followed throughout and the experimental protocol was approved by the local ethics committee for animal experimentation (no. BX0622). Eleven-week-old C57BL/6 male mice (Janvier) were housed in individual plastic cages and adapted to a standard diet (AO4, UAR) for 1 wk. A group of mice received 5 intraperitoneal injections of STZ [45 mg/(kg×d) in a sodium citrate solution, pH 4.5] and others were injected with vehicle alone. We monitored blood glucose concentrations to detect diabetes from the outset and to start the experimental diets for 12 d as follows: 4 shamtreated and 4 diabetic mice had free access to a standard diet (CON and STZ groups, respectively) and 4 sham-treated and 6 diabetic mice had free access to a t10c12CLA diet (CLA and STZ-CLA groups, respectively). Diets described in Degrace et al. (25) consisted of a basal diet enriched either with 1% of 18:1(n-9) (oleic acid) or trans-10,cis-12 18:2 (n-6) (purity 90%), both esterified as TG (Larodan Fine Chemicals). Mice were food-deprived 4 h before anesthesia [ketamine (7.5 mg)/ xylazine (1 mg)/100 g body weight] and tissue handling. Fresh samples of liver were used for slicing procedure and FA oxidation measurements or frozen in liquid nitrogen for further analyses.
Biochemical analyses. Serum variables were determined with commercial kits from Sigma-Diagnostics for glucose (Glucose trinder) and lactate (Lactate reagent), from BioMérieux for TG (TG PAP150) and cholesterol (Cholesterol RTU), and from Mercodia for insulin (Mouse Insulin ELISA). Serum lipoprotein separation was performed by fast performance liquid chromatography (AKTA, Amersham Pharmacia Biotech). Serum (200 mL) was injected in a Superose 6 column (Amersham Pharmacia Biotech) and eluted at 0.3 mL/min with 50 mmol/L Tris, 0.154 mol/L NaCl, 1 mmol/L EDTA, 3.1 mmol/L NaN 3 , pH 7.4. Lipoprotein fractions were detected spectrophotometrically at 280 nm and total cholesterol quantified with a commercial kit from BioMérieux (Cholesterol RTU). The measurement of liver glycogen was carried out after enzymatic hydrolysis according to Bergmeyer et al. (26) and glucose hydrolyzed was quantified as in serum. Malonyl-CoA concentration was determined by HPLC as previously described (25) . Liver total lipids were extracted according to the method of Folch et al. (27) . After mixing thoroughly, 1 mL of organic phase was transferred to a clean tube containing 1 mL of 1% Triton X-100 in chloroform and dried down under nitrogen. The residue was resolubilized in 0.25 mL distilled water and used for determination of TG concentrations using a commercial kit (TG PAP 150, BioMérieux). FA synthase (FAS) activity was determined spectrophotometrically in a liver homogenate using the method of Nekoproeff et al. (28) based on the oxidation of the NADPH. Protein concentrations of liver homogenates were estimated by the bicinchoninic acid procedure (29) using bovine serum albumin (BSA) as standard (Sigma).
FA incorporation and oxidation and apolipoprotein B secretion. Freshly removed livers from CON, STZ, CLA, and STZ-CLA mice were sliced using a Brendel/Vitron slicer in cold and oxygenated Hawk's medium (Sigma). Thin slices (~200 mm) were rinsed with Williams' medium E (Sigma) and incubated at 378C in oxygenated Williams' medium E supplemented with L-carnitine (0.5 mmol/L) in the presence of 0.2 mmol/L of [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] C] palmitic acid (55.5 GBq/mol, PerkinElmer) complexed to albumin (FA:BSA molar ratio 2.5:1). After 4 h of incubation, slices were rinsed with cold PBS and immediately submitted to lipid extraction while incubation medium was used for the determination of apolipoprotein (apoB), labeled CO 2 , and acid-soluble product contents (25) . Incorporation of FA in different lipid classes was determined after separation by TLC on silica gel and radioactivity counting with an AR-2000 imaging scanner (BioScan).
Immunoblotting. Liver pieces from 3 different mice per group were homogenized in a Potter-Elvehjem homogenizer in PBS containing protease and phosphatase inhibitor cocktails (Roche diagnostic) and diluted into 23 sample buffer (125 mmol/L Tris-HCl, pH 6.8, 20% glycerol, 4% SDS, dithiothreitol, 5 mmol/L dithiothreitol, and 5% b-mercaptoethanol). Equal amounts of proteins were separated by electrophoresis on 8% polyacrylamide gels containing 0.1% SDS and transferred onto Hybond-ECL nitrocellulose membranes (Amersham Biosciences). Membranes were then blocked for 1 h at room temperature with 5% BSA in Tris-buffered saline (TBST), 20 mmol/L Tris-HCl, pH 7.4, 500 mmol/L NaCl, 0.1% Tween 20. Membranes were incubated either overnight at 48C with a phospho-AMP kinase a (p-AMPK; Thr172) antibody (dilution 1:1000; Cell Signaling) or 1 h at room temperature with a b-actin antibody (dilution 1:10,000; Sigma). Blots were washed with TBST for 1 h and incubated with secondary antibody, horseradish peroxidase linked to anti-IgG (dilution 1:10,000) for 1 h. Incubation blots were then washed with TBST and visualized with ECL reagents (Amersham Biosciences).
Gene expression. Total mRNA of liver fragments from 4 different mice per group were extracted with Tri-Reagent (Euromedex). Total mRNA was reverse-transcribed using the Iscript cDNA kit (Bio-Rad). For each sample, real-time PCR was performed in triplicate as described previously (22) in a 96-well plate using an iCycler iQ (Bio-Rad). Forward and reverse primers (Supplemental Table 1 ) were designed using 'Primers!' software and were synthesized by MWG-Biotech AG. The relative gene expression quantitation was calculated from standard curves for each gene established using 4 dilutions (1/10 to 1/10000) of cDNA-positive controls and normalized with TATA box binding protein.
Statistical analysis.
Results are expressed as means 6 SEM. Data were analyzed with 2-way ANOVA using Statview (version 5.0). We used the Tukey-Kramer test to identify which specific means differed when the F test for treatment effect was significant. Differences were considered significant at P , 0.05.
Results
Body and organ weights. At the beginning of the experiment, the body weights of mice from the 4 groups were comparable (data not shown). At the end of the treatments, the body weight of all 4 groups differed in the order CON . CLA . STZ-CLA . STZ ( Table 1) . Relative periepididymal adipose tissue masses were less in STZ and CLA than in CON mice, with a more pronounced effect in STZ mice. In contrast, body and relative adipose tissue weights of STZ-CLA mice were higher than in STZ mice, reflecting the interaction of the treatments (P , 0.001). Concomitantly, the relative liver weight was greater in STZ-CLA mice and less in CON mice than in the 2 other groups (P , 0.05) ( Table 1) .
Serum analysis. First, the serum of STZ and STZ-CLA mice was characterized by undetectable insulin levels, low lactate levels, and high glucose concentrations (Table 1) . Surprisingly, feeding t10c12CLA alone did not increase insulin levels, which were slightly lower in CLA than in CON mice (P , 0.05), whereas serum glucose did not differ between the groups.
It is important to note that the serum TG concentration was less in CLA and STZ-CLA mice than in CON and STZ mice, respectively, indicating that consumption of t10c12CLA reduced triglyceridemia in both normal and diabetic mice (P , 0.008) ( Table 1 ). The TG-lowering effect of t10c12CLA was particularly emphasized in diabetic mice, because it prevented the hypertriglyceridemia induced by insulin deficiency. Concomitantly, the serum cholesterol concentration differed in the order STZ . CLA . CON and STZ-CLA mice had cholesterol concentrations that did not differ from those of CLA and CON mice, suggesting that t10c12CLA treatment also prevented the hypercholesterolemia in STZ mice. The HDL, LDL, and VLDL cholesterol concentrations were greater in the STZ mice than in the other groups and were greater in CLA than in CON mice. Interestingly, the concentrations of all 3 were less in STZ-CLA than in STZ mice (Table 1) .
Tissue analysis. Compared with CON mice, the liver TG concentration was 180% higher in CLA mice and 64% lower in STZ mice (Table 1) . Interestingly, the t10c12CLA effect was maintained in mice lacking insulin, because STZ-CLA mice had a 171% higher liver TG concentration than STZ mice. The concentration in STZ-CLA mice did not differ from the CON group. Liver total cholesterol concentrations did not differ among the groups. The liver glycogen concentration in CLA mice did not differ from CON, whereas it was dramatically lower in STZ mice than in the other groups (Table 1) . One particular finding of interest was that the glycogen concentration in STZ-CLA was comparable to CON mice, suggesting that the reduction of glycogen stores in STZ mice was prevented by t10c12CLA feeding.
To examine the mechanisms involved in liver lipid alterations in vivo, we measured, using liver slices, the capacity of the liver to metabolize FA and to secrete apoB particles after the different treatments ( Table 2) . Whereas total FA incorporation into the liver explants was comparable among the groups, FA recovered as FFA tended to be greater in mice fed t10c12CLA (P = 0.09) ( Table 2) . As expected, b-oxidation of palmitic acid was significantly higher in the liver of STZ than in CON mice. Interestingly, t10c12CLA feeding tended to reduce b-oxidation rates (P = 0.06). Thus, b-oxidation of palmitic acid did not differ from the CON group in STZ-CLA mice ( Table 2) . Measurement of apoB particles in the medium at the end of the 4-h incubation period was used as an indicator of VLDL secretion (Table 2) . ApoB secretion in the medium was higher in the STZ-CLA mice than in CON group.
The hepatic malonyl-CoA concentration was very low in STZ mice but did not differ from CON in STZ-CLA mice (Table 1) . Concomitantly, FAS activity was lower in STZ and STZ-CLA than in CON and CLA mice.
Given the central role of AMPK in the regulation of carbohydrate and lipid metabolism and to further investigate the interactions between these pathways, we measured the levels of the activated form of AMPK (p-AMPK) in the liver (Fig. 1) . Levels of p-AMPK were greater in all treated groups than in CON and were greater in STZ mice than in both CLA-treated groups, which did not differ from one another.
Considering the fact that muscle may constitute an important source of lactate for liver glycogen formation, we also measured this variable (Table 1 ). The lactate concentration was 71% greater in STZ-CLA than in other groups, indicating an important effect of t10c12CLA when administered to diabetic mice (P , 0.001). Fig. 2A) and VLDL receptor (VLDLR; Fig. 2B ) expression in CLA and STZ-CLA mice than in CON mice suggested that t10c12CLA could increase liver lipid uptake. The mRNA expression of FAS (Fig. 2C ) tended to be higher in the liver of CLA than in CON mice (P , 0.08), whereas this effect was significant for acetyl-CoA carboxylase (ACC) 1 (Fig. 2D ) and 2 ( Fig. 2E ). These lipogenic enzymes were clearly downregulated in both STZ and STZ-CLA, indicating that t10c12CLA lost its stimulatory effect in STZ-CLA mice.
The expression of stearoyl-CoA desaturase-1 (SCD-1), which converts SFA into monounsaturated FA, was also higher in CLA mice and less in both STZ and STZ-CLA mice than in CON (Fig.  2F) . Interestingly, mRNA levels of the rate-limiting enzyme of long-chain FA oxidation, carnitine palmitoyltransferase I (CPT-I), differed in the order STZ . CLA . CON, whereas in STZ-CLA mice, transcripts were less than STZ and did not differ from CLA, indicating that the stimulatory effect induced by diabetes was limited by t10c12CLA feeding (Fig. 2G ).
Phosphoenolpyruvate carboxykinase (PEPCK) mRNA expression (Fig. 2H ) was higher in both STZ-injected groups than in CON and CLA, which did not differ from one another. It is worth noting that PEPCK expression was less in STZ-CLA than STZ mice, reflecting the interaction of the treatments (P , 0.05). Glucokinase (GK) mRNA expression was considerably lower in STZ and STZ-CLA (Fig. 2I ) than in CLA and CON mice. The expression of glycerol-phosphate deshydrogenase (GPDH), involved in the conversion of glycerol to glucose, was less in STZ-CLA mice than in the CON group (P = 0.04) and was intermediate in the CLA and STZ groups (Fig. 2J) .
Discussion
In most of the studies in mice, t10c12CLA feeding induced insulin resistance and hyperinsulinemia (12, 18, 19, 30) . Because some authors concomitantly reported an increase in mRNA expression and activity of lipogenic enzymes (19, 21) , it has been hypothesized that CLA-induced liver steatosis is partly due to an increase in hepatic lipogenesis stimulated by high insulin levels. To further investigate this idea, we conducted this study using STZ-injected mice to determine whether t10c12CLA could exert some effects on liver metabolism in the absence of insulin. The results demonstrate that t10c12CLA induces liver TG accumulation in the absence of insulin and, thus, support the view that t10c12CLA can improve the activity of metabolic pathways related to carbohydrate and lipid metabolism primarily altered by diabetes induction.
STZ-injected mice exhibited the predicted phenotype with undetectable levels of insulin associated with high glycemia, both attesting to the effectiveness of the injections. These mice also presented a very strong lipoatrophy in conjunction with the absence of insulin, which regulates adipocyte lipolysis and lipid uptake under normal conditions. Concomitantly, STZ-injected mice became hypercholesterolemic and hypertriglyceridemic and lipoprotein analyses indicated that these plasma lipid alterations were essentially due to increases plasma VLDL concentration. Low concentrations of liver TG, low apoB secretion rates, and reduced adiposity support the suggestion that this increase in plasma VLDL concentration was not due to the stimulation of the secretion of the VLDL by STZ treatment but rather to an inhibition of their catabolism in accordance with Mamo et al. (31) .
Feeding control mice with t10c12CLA for 12 d induced partial lipoatrophy and liver TG accumulation. Nevertheless, we did not observe a concomitant increase in insulin levels as described in Poirier et al. (12) . This discrepancy may be attributable to differences in gender or in administration mode 1 Values are means 6 SEM, n = 4-6. Means in a row with superscripts without a common letter differ, P , 0.05. (TG vs. FFA) and duration of t10c12CLA in the 2 studies. In our study, insulinemia was even slightly decreased, likely in conjunction with the amelioration of plasma lipids. In the STZinjected mice, in which levels of insulin were undetectable and the liver depleted in TG, we demonstrated that t10c12CLA feeding also triggered liver TG accumulation. Thus, t10c12CLA feeding contributed to restore TG concentration in the liver of diabetic mice. Reconstitution of fat stores in the livers of STZ-CLA mice may be multifactorial, involving a decrease in FA oxidation and/or an increase in de novo FA synthesis and/or an increase in FA uptake from peripheral fat stores by the hepatocytes. However, in these conditions of insulin deficiency, the contribution of de novo lipogenesis is likely excluded, particularly because t10c12CLA treatment did not induce the expression of FAS, ACC isoforms, and SCD-1 in diabetic mice. Nevertheless, the liver concentration in malonyl-CoA, which is the product of ACC activity and is both an intermediate in FA synthesis and an inhibitor of FA oxidation through allosteric inhibition of CPT-I (32), was restored by t10c12CLA treatment. One explanation may be that t10c12CLA reduced the activity of malonyl-CoA decarboxylase, and thereby the catabolism of malonyl-CoA, primarily induced by STZ as demonstrated in rats (33) . However, both the increased malonyl-CoA levels and the reduced CPT-I gene expression in STZ-CLA mice may explain the reduction of FA oxidation, indirectly promoting TG synthesis.
The current data also raise the possibility that restoration of the TG concentration in livers of STZ-CLA mice was due at least in part to an increase in the lipid flux. This assumption is supported by recent works reporting that t10c12CLA induces the expression of proteins involved in lipid uptake with concomitant alterations of lipoprotein profiles and reduction of triglyceridemia (22) . In STZ-injected mice, the TG-lowering effect of t10c12CLA was particularly emphasized, with a reduction in plasma VLDL, LDL, and HDL cholesterol concentrations suggesting an improvement of lipoprotein clearance. The liver itself could be the main contributor of plasma lipid uptake according to the fact that fat storage was altered in adipose tissue and muscle (data not shown). This consideration is supported by the increased FAT/CD36 and VLDLR expression in both CLA and STZ-CLA mice. FAT/CD36 is a PPARgregulated gene generally poorly expressed in the liver and highly expressed in adipose tissue, skeletal muscle, and heart where it is involved in FA uptake and lipogenesis (34) . Increased FAT/CD36 transcripts could therefore emphasize an improvement in FA utilization by the liver as previously reported (35) .VLDLR is also underexpressed in the liver of adult mice (36) and is considered a peripheral lipoprotein receptor (37) . Nevertheless, an ectopic expression of VLDLR in the liver has already been associated with an increase in plasma lipoprotein clearance (38) .
In diabetic mice, the lack of insulin imposed a switch from glucose to FA for energy production and ketone bodies were generated to supply energy to peripheral tissues, such as the brain and muscles, in replacing glucose. The activation of AMPK in the liver of STZ mice illustrated this metabolic switch, because p-AMPK inhibits lipid synthesis and increases lipid b-oxidation (39) . Interestingly, in STZ-CLA mice, concordant arguments suggest that a transition from a highly glucogenic state primarily induced by diabetes (40) to a more lipogenic state occurred, which may be considered as an improvement of liver metabolism. This concept is supported by the decrease in the p-AMPK protein level, the downregulated expression of PEPCK that catalyzes one of the rate-limiting steps of gluconeogenesis, and the restoration of glycogen stores. The decrease in PEPCK expression, primarily induced by the diabetic process, may be related to an increase in cellular glucose concentration in accordance with previous works, indicating that glucose reduces the rate of PEPCK gene transcription in hepatocytes (41) . Nevertheless, the glycogen accumulation in STZ-CLA mice likely does not correspond to the action of t10c12CLA on plasma glucose utilization because glycemia and GK expression were unchanged, but rather is due to the contribution of glucogenic substrates actively engaged in metabolic pathways. Among these substrates, lactate is now clearly considered an important promoter for glycogen deposition in liver (42), so we assume that lactate, which is highly produced in the muscles of STZ-CLA mice, is readily used as a carbon source for the liver and is responsible for glycogen replenishment. Glycerol derived from TG hydrolysis and amino acids derived from protein breakdown may also have contributed to some extent to glycogen resynthesis (43, 44) , but their relative contributions and that of lactate remain to be established. However, under our conditions, glycerol and amino acid contributions were likely to be excluded, because GPDH mRNA expression was not induced by t10c12CLA, which increases muscular mass (2).
In conclusion, the results of this study suggest that t10c12CLA may stimulate liver lipid accumulation independently of insulin. Whereas there is conflicting information suggesting that t10c12CLA could be responsible for altering carbohydrate and lipid metabolism in rodents (45) , data also suggest that t10c12CLA feeding may have a beneficial impact on the profoundly altered hepatic metabolism of STZ-induced diabetic mice. It appears that t10c12CLA mainly exerted its effects through its capacity to increase uptake and decrease oxidation of FA and concomitantly to supply the liver with more carbon precursors for glycogen synthesis.
